Cargando…

Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review

BACKGROUND: High-grade and recurrent meningiomas are often treatment resistant and pose a therapeutic challenge after surgical and radiation therapy (RT) failure. Temozolomide (TMZ) is a DNA alkylating agent that appears to have a radiosensitizing effect when used in combination with RT and may be w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belanger, Katherine, Ung, Timothy H., Damek, Denise, Lillehei, Kevin O., Ormond, D. Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988385/ https://www.ncbi.nlm.nih.gov/pubmed/35392834 http://dx.doi.org/10.1186/s12885-022-09340-7

Ejemplares similares

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma—A Critical Review
por: Komotar, Ricardo J., et al.
Publicado: (2008)

High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas
por: Tatman, Philip D., et al.
Publicado: (2021)

Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results
por: Oike, Takahiro, et al.
Publicado: (2013)

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
por: Vieito, Maria, et al.
Publicado: (2022)

DIPG-26. THERAPEUTIC EFFECTS OF RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE VERSUS RADIOTHERAPY WITH CONCOMITANT TEMOZOLOMIDE ALONE IN CHILDREN WITH DIPG: A SINGLE-CENTER EXPERIENCE WITH 82 CASES
por: Lai, Mingyao, et al.
Publicado: (2020)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

ODP333 Mucosal-Associated Lymphoid Tissue Lymphoma: a Rare Condition in the Differential Diagnosis of a Parasellar Mass
por: Stortz, Ethan, et al.
Publicado: (2022)

A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide
por: Clavreul, Anne, et al.
Publicado: (2021)

Prognostic Factors for Survival in Patients with High-Grade Meningioma and Recurrence-Risk Stratification for Application of Radiotherapy
por: Yamaguchi, Shigeru, et al.
Publicado: (2014)

Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
por: Hoffmann, Elgin, et al.
Publicado: (2021)

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
por: Ge, Jingjing, et al.
Publicado: (2021)

Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment
por: Zhi, De-Bao, et al.
Publicado: (2021)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
por: Ohno, Makoto, et al.
Publicado: (2019)

Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis
por: Yin, An-an, et al.
Publicado: (2013)

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a “real-life” report
por: Biau, J., et al.
Publicado: (2017)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
por: Nguyen, Ludovic T., et al.
Publicado: (2013)

Toxicity and Outcome of Radiotherapy with Concomitant and Adjuvant Temozolomide in Elderly Patients with Glioblastoma: A Retrospective Study
por: SAITO, Kuniaki, et al.
Publicado: (2014)

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
por: Wang, Yong, et al.
Publicado: (2019)

Histological transformation in recurrent WHO grade I meningiomas
por: Corniola, Marco V., et al.
Publicado: (2020)

Recurrence/Regrowth in Grade I Meningioma: How to Predict?
por: de Carvalho, Gervásio Teles Cardoso, et al.
Publicado: (2020)

Recurrence pattern analysis after [(68)Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas
por: Zollner, Barbara, et al.
Publicado: (2018)

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab
por: Berger, Bernhard, et al.
Publicado: (2008)

3-D conformal radiotherapy with concomitant and adjuvant temozolomide for patients with glioblastoma multiforme and evaluation of prognostic factors
por: Tezcan, Yilmaz, et al.
Publicado: (2011)

A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma
por: Misir Krpan, Ana, et al.
Publicado: (2017)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis
por: Zhao, Qian, et al.
Publicado: (2016)

Radiotherapy for meningiomas
por: Chen, William C., et al.
Publicado: (2022)

Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life
por: Addeo, Raffaele, et al.
Publicado: (2007)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2016)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
por: Wang, Daijun, et al.
Publicado: (2020)

Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification
por: Deng, Maximilian Y, et al.
Publicado: (2023)

Profile Analysis of Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study
por: MATSUDA, Masahide, et al.
Publicado: (2015)

Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide
por: Berger, Kerstin, et al.
Publicado: (2020)

Distinguishing grade I meningioma from higher grade meningiomas without biopsy
por: Varlotto, John, et al.
Publicado: (2015)

Radiotherapy and radiosurgery for meningiomas
por: Chen, William C, et al.
Publicado: (2023)

Temozolomide and Radiotherapy versus Radiotherapy Alone in High Grade Gliomas: A Very Long Term Comparative Study and Literature Review
por: Parisi, Salvatore, et al.
Publicado: (2015)

Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas
por: Li, Depei, et al.
Publicado: (2019)

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
por: Behling, Felix, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bnola9pgnrmdhtrquuk43oku56